The Trend Is Your Friend: Direct Oral Antagonists as Standard Anticoagulants for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interventions

被引：0
作者：
Nordbeck, Peter [1 ,2 ]
Hu, Kai [1 ,2 ]
机构：
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[2] Comprehens Heart Failure Ctr, Wurzburg, Germany
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 77卷 / 02期
关键词：
DABIGATRAN;
D O I：
10.1097/FJC.0000000000000950
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 163
页数：2
相关论文
共 9 条
  • [1] Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
    Cairns, John A.
    Connolly, Stuart
    McMurtry, Sean
    Stephenson, Michael
    Talajic, Mario
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (01) : 74 - 90
  • [2] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [3] Cordero A, 2020, J CARDIOVASC PHARM
  • [4] Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
    Eikelboom, J. W.
    Connolly, S. J.
    Bosch, J.
    Dagenais, G. R.
    Hart, R. G.
    Shestakovska, O.
    Diaz, R.
    Alings, M.
    Lonn, E. M.
    Anand, S. S.
    Widimsky, P.
    Hori, M.
    Avezum, A.
    Piegas, L. S.
    Branch, K. R. H.
    Probstfield, J.
    Bhatt, D. L.
    Zhu, J.
    Liang, Y.
    Maggioni, A. P.
    Lopez-Jaramillo, P.
    O'Donnell, M.
    Kakkar, A. K.
    Fox, K. A. A.
    Parkhomenko, A. N.
    Ertl, G.
    Stoerk, S.
    Keltai, M.
    Ryden, L.
    Pogosova, N.
    Dans, A. L.
    Lanas, F.
    Commerford, P. J.
    Torp-Pedersen, C.
    Guzik, T. J.
    Verhamme, P. B.
    Vinereanu, D.
    Kim, J. -H.
    Tonkin, A. M.
    Lewis, B. S.
    Felix, C.
    Yusoff, K.
    Steg, P. G.
    Metsarinne, K. P.
    Bruns, N. Cook
    Misselwitz, F.
    Chen, E.
    Leong, D.
    Yusuf, S.
    Aboyans, V.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) : 1319 - 1330
  • [5] Successful COMPASS, Disappointing COMMANDER HF, What Have We Learned From These Two Trials?
    He, Yuhu
    Hu, Xinqun
    Zhou, Shenghua
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (04) : 306 - 307
  • [6] 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) (vol 42, pg 373, 2021)
    Hindricks, G.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (05) : 546 - 547
  • [7] Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
    Schaefer, Andreas
    Flierl, Ulrike
    Bauersachs, Johann
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (06) : 759 - 774
  • [8] Dabigatran Association With Higher Risk of Acute Coronary Events Meta-analysis of Noninferiority Randomized Controlled Trials
    Uchino, Ken
    Hernandez, Adrian V.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (05) : 397 - 402
  • [9] Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
    Zannad, Faiez
    Anker, Stefan D.
    Byra, William M.
    Cleland, John G. F.
    Fu, Min
    Gheorghiade, Mihai
    Lam, Carolyn S. P.
    Mehra, Mandeep R.
    Neaton, James D.
    Nessel, Christopher C.
    Spiro, Theodore E.
    van Veldhuisen, Dirk J.
    Greenberg, Barry
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14) : 1332 - 1342
1